Idioma:

A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

Lindström, Sara ; Ma, Jing ; Altshuler, David ; Giovannucci, Edward ; Riboli, Elio ; Albanes, Demetrius ; Allen, Naomi E ; Berndt, Sonja I ; Boeing, Heiner ; Bueno-de-Mesquita, H. Bas ; Chanock, Stephen J ; Dunning, Alison M ; Feigelson, Heather Spencer ; Gaziano, J. Michael ; Haiman, Christopher A ; Hayes, Richard B ; Henderson, Brian E ; Hunter, David J ; Kaaks, Rudolf ; Kolonel, Laurence N ; Le Marchand, Loic ; Martínez, Carmen ; Overvad, Kim ; Siddiq, Afshan ; Stampfer, Meir ; Stattin, Pär ; Stram, Daniel O ; Thun, Michael J ; Trichopoulos, Dimitrios ; Tumino, Rosario ; Virtamo, Jarmo ; Weinstein, Stephanie J ; Yeager, Meredith ; Kraft, Peter ; Freedman, Matthew L

The journal of clinical endocrinology and metabolism, 2010-09, Vol.95 (9), p.E121-E127 [Periódico revisado por pares]

United States: Endocrine Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Autor: Lindström, Sara ; Ma, Jing ; Altshuler, David ; Giovannucci, Edward ; Riboli, Elio ; Albanes, Demetrius ; Allen, Naomi E ; Berndt, Sonja I ; Boeing, Heiner ; Bueno-de-Mesquita, H. Bas ; Chanock, Stephen J ; Dunning, Alison M ; Feigelson, Heather Spencer ; Gaziano, J. Michael ; Haiman, Christopher A ; Hayes, Richard B ; Henderson, Brian E ; Hunter, David J ; Kaaks, Rudolf ; Kolonel, Laurence N ; Le Marchand, Loic ; Martínez, Carmen ; Overvad, Kim ; Siddiq, Afshan ; Stampfer, Meir ; Stattin, Pär ; Stram, Daniel O ; Thun, Michael J ; Trichopoulos, Dimitrios ; Tumino, Rosario ; Virtamo, Jarmo ; Weinstein, Stephanie J ; Yeager, Meredith ; Kraft, Peter ; Freedman, Matthew L
Assuntos: Aged ; Breast Neoplasms - genetics ; Carcinoma - blood ; Carcinoma - genetics ; Case-Control Studies ; Cohort Studies ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; Germ-Line Mutation - physiology ; Gonadal Steroid Hormones - blood ; Humans ; Male ; Middle Aged ; National Cancer Institute (U.S.) ; Original ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - genetics ; Receptors, Androgen - genetics ; Risk ; Trinucleotide Repeats - genetics ; United States
É parte de: The journal of clinical endocrinology and metabolism, 2010-09, Vol.95 (9), p.E121-E127
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author Affiliations are shown at the bottom of next page.
P.K. and M.L.F. contributed equally to this work.
Address all correspondence and requests for reprints to: Matthew L. Freedman, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115. E-mail: mfreedman@partners.org.
Descrição: Background: Androgens are key regulators of prostate gland maintenance and prostate cancer growth, and androgen deprivation therapy has been the mainstay of treatment for advanced prostate cancer for many years. A long-standing hypothesis has been that inherited variation in the androgen receptor (AR) gene plays a role in prostate cancer initiation. However, studies to date have been inconclusive and often suffered from small sample sizes. Objective and Methods: We investigated the association of AR sequence variants with circulating sex hormone levels and prostate cancer risk in 6058 prostate cancer cases and 6725 controls of Caucasian origin within the Breast and Prostate Cancer Cohort Consortium. We genotyped a highly polymorphic CAG microsatellite in exon 1 and six haplotype tagging single nucleotide polymorphisms and tested each genetic variant for association with prostate cancer risk and with sex steroid levels. Results: We observed no association between AR genetic variants and prostate cancer risk. However, there was a strong association between longer CAG repeats and higher levels of testosterone (P = 4.73 × 10−5) and estradiol (P = 0.0002), although the amount of variance explained was small (0.4 and 0.7%, respectively). Conclusions: This study is the largest to date investigating AR sequence variants, sex steroid levels, and prostate cancer risk. Although we observed no association between AR sequence variants and prostate cancer risk, our results support earlier findings of a relation between the number of CAG repeats and circulating levels of testosterone and estradiol.
Editor: United States: Endocrine Society
Idioma: Inglês

Links

Voltar para lista de resultados

Anterior Resultado 9 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

United States: Endocrine Society

Buscando em bases de dados remotas. Favor aguardar.